<DOC>
	<DOC>NCT01495338</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety and comfort of AC-170 compared to a placebo.</brief_summary>
	<brief_title>A Comparison of the Safety and Comfort of AC-170</brief_title>
	<detailed_description />
	<mesh_term>Cetirizine</mesh_term>
	<mesh_term>Olopatadine Hydrochloride</mesh_term>
	<criteria>Able and willing to avoid the use of ocular medications or topical ocular preparations within protocol specific time period. Known contraindications or sensitivities to the study medication or its components. Any ocular condition that, in the opinion of the investigator, could affect the subjects safety or trial parameters. Use of disallowed medications during the period indicated prior to the study enrollment or during the study.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>